LONP1 and cancer: Moreover, since recent studies suggest ClpXP and LonP1 synergistically regulate cancer cell survival [189], preclinical and clinical studies on combination therapy of ClpXP regulators and other mitoproteases regulators may provide even broader applications of ClpXP regulators in newly-diagnosed and relapsed cancers.